Back to shop

Gelucire® 59/14

0.00

Clear
-
+

Total:

Description

Gattefossé widens its range of functional excipients for oral bioavailability enhancement with a new grade of Gelucire®: Gelucire® 59/14, a mixture of lauroyl PEG-32 glycerides EP/NF and PEG 6000 EP/NF.

Gelucire® 59/14 is a self-emulsifying excipient used for oral bioavailability enhancement of poorly water-soluble drugs, owing to its high solubilizing capacity. Gelucire® 59/14 is supplied in pellets, which makes it easy to handle and an interesting add-on to Gattefossé’s Gelucire® range.

gelucire product family

Gelucire® 59/14 is a self-emulsifying system: upon contact with aqueous or digestive media it spontaneously forms a fine dispersion.  The different components self-assemble as a function of their affinity for water, resulting in the formation of micelles, wherein the drug is solubilized. This mechanism contributes to an increased absorption and hence bioavailability of drugs.

Gelucire® 59_14 Self-emulsifying system

More information on lipid-based formulation development can be found here!

Additional information

Manufacturer

Gattefosse

Quality

EP, USP-NF

Dosage Form

Pellets

Function

Single excipient formulation system: self-emulsifies in aqueous fluid into microemulsion—LFCS Type III (SMEDDS), Solubilizer for poorly-soluble APIs and bioavailability enhancer.

Composition

Consists of a small fraction of mono, di- and triglycerides and mainly PEG-32 (MW 1500) mono- and diesters of lauric acid (C12) and of PEG-150 (MW 6000)

Synonym

Mixture of Lauroyl Macrogol-32 glycerides and PEG 6000, Mixture of Lauroyl Polyoxyl-32 glycerides and PEG 6000

Documents and Links

You may also like…

Labrafil M 1944 CS

0.00
Gattefosse Select options

Labrasol

0.00
Gattefosse Select options

Transcutol P

0.00
Gattefosse Select options